2 completed, 1 recruiting, 1 withdrawn. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 1, Withdrawn 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow University of Exeter: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phenserine on the Alzheimer's Treatment Horizon, Study 1 Phenserine, Donepezil (Aricept®) - Alzheimer Disease, Mild Cognitive Impairment | Phase 1 | Completed | Helse Stavanger HF | 16 | 2025-02-01 | 2026-05-04 |
| Ketamine for Combined Depression and Alcohol Use Disorder Ketamine Hydrochloride, Midazolam Hydrochloride - Depression, Alcohol Use Disorder | Phase 1 / Phase 2 | Recruiting | University Hospital of North Norway | 34 | 2025-01-20 | 2026-06-23 |
| Effect of Basis™ and High Intensity Interval Training (HIIT) on Muscle Metabolism and Exercise Performance NRPT, Placebo oral capsule - Healthy | Phase 1 | Withdrawn | Elysium Health | 2023-02-01 | 2023-02-15 | |
| Rehabilitation Training After Stroke Rehabilitation - Stroke | Phase 1 | Completed | University of Exeter | 48 | 2015-07-31 | 2019-03-19 |
Alcoholism (1) · Alzheimer Disease (1) · Behavior, Addictive (1) · Cognitive Dysfunction (1) · Depression (1) · Stroke (1)
Donepezil (1) · Ketamine (1) · Midazolam (1) · Rehabilitation (1) · phenserine (1)
Norway (2) · United Kingdom (2)
Andreas W Blomkvist, M.D. (1) · Anne Forster, Prof (1) · Anne Spencer, Prof (1) · Leon Poltawski, Dr (1) · Martin James, Dr (1) · Meriel Norris, Dr (1) · Rhoda Allison, Dr (1) · Rod Taylor, Prof (1) · Sarah Dean, PhD (1) · Shirley Stevens, Mrs (1) · Timothy Etheridge, PhD (1)
PMID 27697876, PMID 29449290, PMID 30049699, PMID 31443735, PMID 34767488, PMID 41587390
2023 (1)